Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nicola Lahoud"'
Publikováno v:
PLoS ONE, Vol 17, Iss 1 (2022)
Background/Objectives Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy associated with high metastatic risk. Prognosis remains poor even after resection. Previously our group identified biomarkers that improved diagnostic accuracy
Externí odkaz:
https://doaj.org/article/639b2cbd91f148718c621741f3d5d9ba
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0221169 (2019)
BackgroundEarly diagnosis of pancreatic ductal adenocarcinoma (PDAC) is challenged by the absence of accurate early diagnostic and prognostic biomarkers. CA19-9 is the established, diagnostic tumour marker in PDAC, despite its limitations. Effective
Externí odkaz:
https://doaj.org/article/6f505dca8f7d4f09871ddcf8e63dc589
Publikováno v:
PLoS ONE
PLoS ONE, Vol 17, Iss 1 (2022)
PLoS ONE, Vol 17, Iss 1, p e0262439 (2022)
PLoS ONE, Vol 17, Iss 1 (2022)
PLoS ONE, Vol 17, Iss 1, p e0262439 (2022)
Background/Objectives Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy associated with high metastatic risk. Prognosis remains poor even after resection. Previously our group identified biomarkers that improved diagnostic accuracy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::301e32fe8f5d43d8ff1bddefcf869cfb
https://pubmed.ncbi.nlm.nih.gov/35020761
https://pubmed.ncbi.nlm.nih.gov/35020761
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0221169 (2019)
PLoS ONE
PLoS ONE
BackgroundEarly diagnosis of pancreatic ductal adenocarcinoma (PDAC) is challenged by the absence of accurate early diagnostic and prognostic biomarkers. CA19-9 is the established, diagnostic tumour marker in PDAC, despite its limitations. Effective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c1e02eba96c8b6e7f99a6bec7e71823
https://doaj.org/article/6f505dca8f7d4f09871ddcf8e63dc589
https://doaj.org/article/6f505dca8f7d4f09871ddcf8e63dc589